Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.5115
+0.0160 (3.23%)
At close: Jan 23, 2026

Ayala Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022
Period Ending
Jan '26 Dec '23 Dec '22
308-
Enterprise Value
-7-
Last Close Price
0.510.67-
PS Ratio
2333.41610.40-
PB Ratio
-1.24-0.32-
EV/Sales Ratio
-559.86-
Debt / Equity Ratio
-0.34-0.34-1.59
Asset Turnover
0.000.00-
Quick Ratio
0.200.200.43
Current Ratio
0.300.300.51
Return on Assets (ROA)
-181.05%-181.05%-
Return on Capital Employed (ROCE)
417.90%417.90%-2391.80%
Earnings Yield
-158.47%-605.81%-
Buyback Yield / Dilution
--107.90%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.